» Articles » PMID: 36867230

Perioperative Outcomes of Minimally Invasive Surgery for Large Malignant Thymic Epithelial Tumors and for Total Thymectomy

Overview
Journal Surg Today
Specialty General Surgery
Date 2023 Mar 3
PMID 36867230
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Minimally invasive surgery (MIS) for thymic tumors is now accepted widely, in line with improved surgical techniques; however, we occasionally encounter complicated cases of large tumors or of total thymectomy requiring prolonged operative duration or conversion to an open procedure (OP). We reviewed patients registered in a nationwide database to identify the technical feasibility of MIS for thymic epithelial tumors.

Methods: Data on patients treated surgically between 2017 and 2019 were extracted from the National Clinical Database of Japan. Clinical factors and operative outcomes were calculated by tumor diameter using trend analyses. Perioperative outcomes of MIS for non-invasive thymoma were investigated using propensity score-matched analyses.

Results: MIS was performed in 46.2% of the patients. The operative duration and conversion rate increased with the tumor diameter (p < .001). After propensity score-matching, operative duration and postoperative hospital stay were shorter (p < .001), and the transfusion rate was lower (p = .007) in patients who underwent MIS than in those who underwent OP for thymomas ≥ 5 cm. Among patients who underwent total thymectomy, blood loss was less (p < .001) and the postoperative hospital stay was shorter (p < .001) in those who underwent MIS than in those who underwent OP. There were no significant differences in postoperative complications and mortality.

Conclusions: MIS is technically feasible even for large non-invasive thymomas or for total thymectomy, although the operative duration and open conversion rate increase with the tumor diameter.

References
1.
Friedant A, Handorf E, Su S, Scott W . Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis. J Thorac Oncol. 2016; 11(1):30-8. PMC: 7560956. DOI: 10.1016/j.jtho.2015.08.004. View

2.
Burt B, Yao X, Shrager J, Antonicelli A, Padda S, Reiss J . Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry. J Thorac Oncol. 2016; 12(1):129-136. PMC: 5428544. DOI: 10.1016/j.jtho.2016.08.131. View

3.
Salfity H, Timsina L, Ceppa D, Birdas T . Minimally invasive surgery in the management of resectable thymoma: a retrospective analysis from the National Cancer Database. J Thorac Dis. 2022; 13(11):6353-6362. PMC: 8662507. DOI: 10.21037/jtd-20-2660. View

4.
Marulli G, Rea F, Melfi F, Schmid T, Ismail M, Fanucchi O . Robot-aided thoracoscopic thymectomy for early-stage thymoma: a multicenter European study. J Thorac Cardiovasc Surg. 2012; 144(5):1125-30. DOI: 10.1016/j.jtcvs.2012.07.082. View

5.
Raja S, Guptill J, McConnell A, Al-Khalidi H, Hartwig M, Klapper J . Perioperative Outcomes of Thymectomy in Myasthenia Gravis: A Thoracic Surgery Database Analysis. Ann Thorac Surg. 2021; 113(3):904-910. DOI: 10.1016/j.athoracsur.2021.06.071. View